Cystic Fibrosis in Non-White Newborns More Likely Missed in Screenings
Cystic fibrosis is often missed in newborn screenings for non-white babies, creating higher risk for other races.
Cystic fibrosis is often missed in newborn screenings for non-white babies, creating higher risk for other races.
New research provides insights on the effects of cystic fibrosis in the kidneys, pointing to the potential for a urine test related to the disease.
The test enables highly automated screening for latent tuberculosis.
Study subjects with uncontrolled asthma had substantially higher levels of local IL-26 in their airways, when compared with subjects with controlled asthma.
Read MoreAccess to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals.
Read MoreThe panel is the first offering in a deep and broad pipeline of assays planned for QIAstat-Dx in the United States.
Read MoreThe study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read MoreThe BD Max MDR-TB panel has obtained the CE mark, supporting market launch in Europe.
Read MoreThe test uses genetic biomarkers to determine with high accuracy whether inhaled substances and chemicals that come into contact with the lungs are allergenic or not.
Read MoreAs soon as a baby is born, its immune system starts to change dramatically in response to the bacteria and viruses in its new environment. The study was made possible using new techniques of immune cell analysis.
Read MoreNew module expands molecular testing capabilities, increases productivity and flexibility for the laboratory.
Read MoreliTechGroup Molecular Diagnostics has launched a multiplex assay, the respiratory bacterial Elite MGB panel, for the diagnosis of bacterial respiratory infections.
Read MoreRunning on the company’s Panther Fusion system, the new assay detects adenovirus, human metapneumovirus, and rhinovirus.
Read MoreHologic has received premarket notification (510(k)) clearance from FDA for its Panther Fusion Flu A/B/RSV assay running on the company’s new Panther Fusion system.
Read MoreARUP Laboratories and IDbyDNA have announced the launch of Explify Respiratory, a next-generation sequencing test for respiratory infections.
Read MoreThe ePlex diagnostic platform integrates nucleic acid extraction, amplification, and detection into a fully automated, sample-to-answer system.
Read MoreProtecting sample stability ensures the utility of the latest generation of TB tests.
Read MoreThe US National Tuberculosis Controllers Association and the Association of Public Health Laboratories have recommended the use of the Xpert MTB/RIF test to support decisionmaking on using airborne infection isolation in healthcare settings.
Read More